Key result
Early data evaluate percutaneous venous valve bioprostheses for safety and efficacy in chronic deep venous insufficiency.
Why the study?
Most patients with chronic deep venous insufficiency are not candidates for direct deep vein valve repair or valve transplantation, and percutaneous venous valve bioprosthesis may improve venous hemodynamics.
Does a percutaneous venous valve bioprosthesis provide safety, patency, and efficacy in patients with chronic deep venous insufficiency?
Does a percutaneous venous valve bioprosthesis provide safety, patency, and efficacy in patients with chronic deep venous insufficiency?
Initial observations from a Phase I trial suggest the feasibility of evaluating a percutaneous venous valve bioprosthesis for chronic deep venous insufficiency.
Answers are grounded in this paper and cite their sources.
Does not support clinical use; leaves open the safety and efficacy of percutaneous venous valve bioprosthesis in chronic deep venous insufficiency.
Chronic deep venous insufficiency remains a major health problem in the United States and worldwide. Selected patients benefit from direct deep vein valve repair or valve transplantation; however, most are not candidates for these procedures. Experience with the bovine monocusp venous valve surgically inserted into the common femoral vein (CFV) demonstrates potential benefit and good long-term patency. A venous valve placed distal to the CFV via percutaneous access has great appeal and potential for further improving venous hemodynamics, as well as reducing ambulatory venous hypertension and ulceration. Two patients were treated with a percutaneous venous valve bioprosthesis as part of a Phase I trial. The primary objective was to evaluate the safety, patency, and efficacy of the percutaneous venous valve bioprosthesis to restore competency to the deep venous system.
No takes yet. Share an insight, caveat, or question.
Gale et al. (2004) studied Chronic deep venous insufficiency (n=2). Percutaneous venous valve bioprosthesis was evaluated on Safety, patency, and efficacy to restore competency to the deep venous system.
Synapse has enriched 10 related papers. Consider them for comparative context: